Single Incision Versus Standard Laparoscopic Splenectomy
NCT01276561 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2017-02-03
Summary
This is a prospective trial of single incision versus standard 4-port laparoscopic splenectomy.
The hypothesis is that there may be a difference in wound infection rates, operative time, doses of analgesics post-operatively, and patient/parent perception of scars. However, the technical difficulty is considerable and the primary outcome is operative time which will be expressed in minutes.
Conditions
- Hereditary Spherocytosis
- Idiopathic Thrombocytopenic Purpura
Interventions
- PROCEDURE
-
Single Incision Splenectomy
Patients will undergo laparoscopic splenectomy through a single incision
- PROCEDURE
-
Laparoscopic Splenectomy
Patients will undergo laparoscopic splenectomy with 4 ports, placement is surgeon dependent
Sponsors & Collaborators
-
Children's Mercy Hospital Kansas City
lead OTHER
Principal Investigators
-
Shawn D St. Peter, MD · Children's Mercy Hospital Kansas City
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2016-10-31
- Completion
- 2017-04-30
Countries
- United States
Study Locations
More Related Trials
-
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
NCT05654766 ·Status: UNKNOWN
-
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
NCT03998059 ·Status: RECRUITING
-
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
NCT06291415 ·Status: WITHDRAWN ·Phase: PHASE1
-
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
NCT00102323 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects
NCT05088642 ·Status: COMPLETED ·Phase: PHASE1
-
Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
NCT00914927 ·Status: COMPLETED ·Phase: PHASE2
-
Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation
NCT01886248 ·Status: UNKNOWN ·Phase: PHASE2
-
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
NCT04262141 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pediatric Disease Registry in Essential Thrombocythaemia (ET)
NCT01198717 ·Status: COMPLETED
-
Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy
NCT05442632 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00037791 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
NCT02851407 ·Status: COMPLETED ·Phase: PHASE3
-
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)
NCT03469661 ·Status: COMPLETED
-
Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
NCT01998828 ·Status: TERMINATED ·Phase: PHASE2
-
TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.
NCT02063763 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia
NCT02227693 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)
NCT01129024 ·Status: TERMINATED ·Phase: PHASE2
-
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
NCT01566695 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
NCT03195010 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
NCT02912884 ·Status: COMPLETED
-
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
NCT04516967 ·Status: COMPLETED ·Phase: PHASE3
-
The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
NCT06507436 ·Status: RECRUITING ·Phase: PHASE3
-
A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)
NCT05426369 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Phase I Study to Evaluate rhTPO in Healthy Caucasian Volunteers
NCT06630494 ·Status: COMPLETED ·Phase: PHASE1
-
NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults
NCT01172015 ·Status: COMPLETED ·Phase: NA